| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 66.10 | 52.74 | 31.04 | 34.89 |
| Cash Equivalents | 11.78 | 13.35 | 0.61 | 0.22 |
| Other Liabilities Total | 0.00 | - | - | 0.00 |
| Long Term Debt | 2.01 | 0.00 | 0.00 | 0.05 |
| Common Stock Total | 13.76 | 12.87 | 8.32 | 8.32 |
| Other Current Assets Total | 4.54 | 1.06 | 0.68 | 1.97 |
| Total Assets | 66.10 | 52.74 | 31.04 | 34.89 |
| Total Equity | 56.79 | 50.68 | 29.42 | 28.63 |
| Long Term Investments | 7.15 | 4.02 | 1.18 | 5.87 |
| Retained Earnings( Accumulated Deficit) | 43.03 | 37.81 | 21.11 | 20.31 |
| Total Common Shares Outstanding | 1.39 | 1.39 | 0.96 | 0.96 |
| Tangible Book Valueper Share Common Eq | 40.97 | 36.56 | 30.66 | 29.83 |
| Total Liabilities | 9.31 | 2.06 | 1.62 | 6.26 |
| Total Debt | 2.76 | 0.00 | 0.05 | 4.63 |
| Cashand Short Term Investments | 11.78 | 13.35 | 0.61 | 0.45 |
| Total Receivables Net | 10.79 | 13.13 | 7.11 | 4.56 |
| Notes Payable/ Short Term Debt | 0.76 | 0.00 | 0.00 | 4.50 |
| Deferred Income Tax | 0.82 | 0.56 | 0.42 | 0.20 |
| Accounts Receivable- Trade Net | 10.79 | 13.13 | 7.11 | 4.56 |
| Property/ Plant/ Equipment Total- Net | 23.12 | 13.57 | 13.88 | 14.29 |
| Minority Interest | 0.22 | - | - | - |
| Total Current Liabilities | 6.27 | 1.50 | 1.20 | 6.01 |
| Total Inventory | 5.77 | 3.39 | 0.91 | 5.46 |
| Accounts Payable | 3.31 | 1.38 | 1.05 | 1.35 |
| Other Currentliabilities Total | 2.20 | 0.12 | 0.10 | 0.08 |
| Total Long Term Debt | 2.01 | 0.00 | 0.00 | 0.05 |
| Other Long Term Assets Total | 0.00 | 0.00 | - | 0.00 |
| Note Receivable- Long Term | 2.95 | 4.23 | 6.68 | 2.30 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 32.88 | 30.93 | 9.30 | 12.44 |
| Current Portof LT Debt/ Capital Leases | - | 0.00 | 0.05 | 0.07 |
| Short Term Investments | - | - | - | 0.23 |
Eiko Lifesciences Dividend Eiko Lifesciences Bonus Eiko Lifesciences News Eiko Lifesciences AGM Eiko Lifesciences Rights Eiko Lifesciences Splits Eiko Lifesciences Board Meetings Eiko Lifesciences Key Metrics Eiko Lifesciences Shareholdings Eiko Lifesciences Profit Loss Eiko Lifesciences Cashflow Eiko Lifesciences Q1 Results Eiko Lifesciences Q2 Results Eiko Lifesciences Q3 Results Eiko Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks